UnitedHealth Group (UNH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
UnitedHealth Group has delivered a 41.5% return over the past year, yet its valuation checks paint a more mixed picture, leaving investors weighing a strong share price run against what the broader ...
UnitedHealth Group has rebounded from a bad 2025.
It has been an unfortunate past few years for one of the country's largest healthcare companies, UnitedHealth Group (NYSE: UNH). There has been no shortage of bad PR, a changing business landscape, ...
The healthcare giant is scheduled to release its second-quarter results in a few weeks.
UnitedHealth Group (UNH) faced a punishing week as shares tumbled nearly 20% on Tuesday following a one-two punch of disappointing Q4 earnings and an unexpected Medicare Advantage rate proposal from ...
UnitedHealth Group Incorporated remains a contrarian Buy after a sharp selloff, with recent Medicare Advantage rate news pressuring margins and investor sentiment. UNH expects 2026 revenues to decline ...
With a 15% share of the total U.S. insurance market and over 47 million members and growing, UnitedHealth Group (NYSE:UNH) remains the top beneficiary of key demographic factors in the US. What are ...